Implanet SA (PA:ALIMP) — Market Cap & Net Worth
Market Cap & Net Worth: Implanet SA (ALIMP)
Implanet SA (PA:ALIMP) has a market capitalization of $32.93 Million (€28.17 Million) as of May 4, 2026. Listed on the PA stock exchange, this France-based company holds position #23405 globally and #374 in its home market, demonstrating a -5.58% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Implanet SA's stock price €0.20 by its total outstanding shares 143818971 (143.82 Million). Analyse ALIMP cash generation efficiency to see how efficiently the company converts income to cash.
Implanet SA Market Cap History: 2015 to 2026
Implanet SA's market capitalization history from 2015 to 2026. Data shows change from $385.04 Million to $33.02 Million (-44.41% CAGR).
Implanet SA Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Implanet SA's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
2.04x
Implanet SA's market cap is 2.04 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $385.04 Million | $6.65 Million | -$8.01 Million | 57.87x | N/A |
| 2016 | $5.38 Billion | $7.83 Million | -$7.29 Million | 687.60x | N/A |
| 2017 | $2.82 Billion | $7.84 Million | -$6.61 Million | 360.25x | N/A |
| 2018 | $948.31 Million | $6.72 Million | -$5.55 Million | 141.12x | N/A |
| 2019 | $462.05 Million | $7.41 Million | -$3.65 Million | 62.38x | N/A |
| 2020 | $188.65 Million | $3.89 Million | -$3.98 Million | 48.47x | N/A |
| 2021 | $51.70 Million | $6.14 Million | -$4.61 Million | 8.42x | N/A |
| 2022 | $28.11 Million | $8.03 Million | -$3.54 Million | 3.50x | N/A |
| 2023 | $10.76 Million | $7.45 Million | -$6.68 Million | 1.45x | N/A |
| 2024 | $19.17 Million | $9.41 Million | -$4.37 Million | 2.04x | N/A |
Competitor Companies of ALIMP by Market Capitalization
Companies near Implanet SA in the global market cap rankings as of May 4, 2026.
Key companies related to Implanet SA by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #141 globally with a market cap of $155.56 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #208 globally with a market cap of $112.79 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #230 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
- Medtronic PLC (NYSE:MDT): Ranked #236 globally with a market cap of $102.56 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #141 | Abbott Laboratories | NYSE:ABT | $155.56 Billion | $89.46 |
| #208 | Stryker Corporation | NYSE:SYK | $112.79 Billion | $294.73 |
| #230 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
| #236 | Medtronic PLC | NYSE:MDT | $102.56 Billion | $80.00 |
Implanet SA Historical Marketcap From 2015 to 2026
Between 2015 and today, Implanet SA's market cap moved from $385.04 Million to $ 33.02 Million, with a yearly change of -44.41%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €33.02 Million | -1.06% |
| 2025 | €33.38 Million | +74.12% |
| 2024 | €19.17 Million | +78.12% |
| 2023 | €10.76 Million | -61.72% |
| 2022 | €28.11 Million | -45.63% |
| 2021 | €51.70 Million | -72.59% |
| 2020 | €188.65 Million | -59.17% |
| 2019 | €462.05 Million | -51.28% |
| 2018 | €948.31 Million | -66.43% |
| 2017 | €2.82 Billion | -47.50% |
| 2016 | €5.38 Billion | +1297.38% |
| 2015 | €385.04 Million | -- |
End of Day Market Cap According to Different Sources
On May 3rd, 2026 the market cap of Implanet SA was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $32.93 Million USD |
| MoneyControl | $32.93 Million USD |
| MarketWatch | $32.93 Million USD |
| marketcap.company | $32.93 Million USD |
| Reuters | $32.93 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Implanet SA
Implanet S.A., together with its subsidiaries, manufactures and sells implants and medical instruments for orthopedic surgery in France, the United States, Europe, the Middle East, Africa, and internationally. The company offers spinal and knee products, including Jazz PF, Jazz Evo, Jazz Cap SP, Jazz Passer, Jazz Lock, Jazz Claw, and Jazz Frame, as well as ISS-Jazz Screw systems for posterior fix… Read more